Eating disorders (ED) are serious mental illnesses with an excess mortality and many affects in the quality of life of patients and thier relatives. Management of ED is very difficult : the prognosis remains relatively poor both in terms of remission rate and quality of life. In this context, the contribution of new strategies for pathophysiological exploration and the development of therapeutic options are crucial. In this project the investigators aim to constitute un cohort of patients from a day unit specialized in the management of ED. A prospective follow-up will be offered to patients to assess their clinical and psycho-social evolution. The overall objective is to identify which factors are prognostic of clinical improvement of the ED. We also want to better characterize patients that will migrate from diagnosis to another.
The investigators propose to assess, with a cohort of patients with ED the prognostic value of cognitive abnormalities associated with ED (cognitive flexibility and central coherence) They will recruit 370 patients suffering from a current ED (anorexia, bulimia, binge eating disorder, Eating disorder not otherwise specified). Each patient will be reassessed every year for 3 years.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
370
Clinical assessment with questionnaires
Frequency of remission rates
study of remission rates frequency at 12 months depending on the Brixton score assessed at baseline (assessment of cognitive flexibility). Remission is defined as disappearance of ED Diagnostic and Statistical Manual (DSM) criteria.
Time frame: At the inclusion and at 12, 24 and 36 months
score to another neuropsychological test (Iowa gambling task (IGT)
Study of remission rates frequency at 12 months depending on the IGT score (decision making) assessed at baseline
Time frame: At the inclusion and at 12, 24 and 36 months
scores to another other neuropsychological test : Rey-Osterrieth complex figure
Study of remission rates frequency at 12 months depending on the Rey figure assessed at baseline
Time frame: At the inclusion and at 12, 24 and 36 months
scores to another neuropsychological test : D2 test of attention
Study of remission rates frequency at 12 months depending on the D2 test (attention) assessed at baseline
Time frame: At the inclusion and at 12, 24 and 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.